LTR Pharma to Conduct Bioequivalence Clinical Trial for Spontan in Q1 2024
LTR Pharma to Conduct Bioequivalence Clinical Trial for Spontan in Q1 2024
LTR Pharma 將於 2024 年第一季度對 Spontan 進行生物等效性臨床試驗
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊